Midostaurin Maintenance Improved Survival in FLT3-Mutated Acute Myeloid Leukemia

Midostaurin maintenance appeared safe and was linked to a survival benefit for low- to intermediate-risk patients with FLT3-mutated acute myeloid leukemia.

Related Keywords

Spain ,Madrid , ,Meeting Of The Society Hematologic Oncology ,Md Anderson Cancer Center Madrid ,Eastern Cooperative Oncology Group ,Annual Meeting ,Hematologic Oncology ,Adolfo De La Fuente ,Cancer Center Madrid ,European Leukemianet ,